Published in Cancer Weekly, January 24th, 2006
"Defective apoptosis signaling is a typical feature of classic Hodgkin lymphoma, multiple myeloma, and activated B-cell-like diffuse large B-cell lymphoma. In these malignancies, the transcription factor NF-kappa B is a critical mediator of apoptosis resistance and oncogenic growth, making it an attractive therapeutic target."
"Here," wrote R.K....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.